Although the metabolomic study used urine samples in patients with diabetes mellitus who had taken SGLT2 inhibitors11, the metabolomics of kidney cells under high glucose conditions and with SGLT2 inhibitors have not been investigated. Here, SLC5A2 is linked to diabetes mellitus.